MedWatch·Industry news·Business & finance·2d agoWSA spends EUR 28m on layoffs: “We will continue to manage the business prudently”WSA has spent EUR 28 million on layoff severance costs, with CEO Jan Mäkelä declining to rule out further cost reductions as the company manages ongoing restructuring.+Save
MedWatch·Industry news·Business & finance·3d agoWSA says cyberattack will have only "limited" financial impactWSA CEO Jan Mäkelä says the company's late-October cyberattack will have only limited financial impact, citing a fast response and cyber insurance coverage.+Save
MedWatch·Industry news·Business & finance·3d agoWSA CEO expects to gain market share despite US headwindWSA CEO Jan Mäkelä states the company expects to gain market share despite losing a managed care contract and issuing guidance well below competitors Demant and Sonova.+Save
MedWatch·Industry news·Business & finance·3d agoWidex heir returns to WSA’s top as new vice chairJulian Tøpholm, heir to the Widex founding family, has rejoined the WSA board as vice chair, representing the owner families, one year after his departure.+Save
MedWatch·Financial report·Business & finance·3d agoWSA loses wholesale market share in launch-heavy quarterWSA reportedly lost wholesale market share during a launch-heavy quarter coinciding with the introduction of its new flagship hearing aid platform, Signia MaX.+Save
MedWatch·Industry news·Business & finance·3d agoLoss of major US customer weighs on WSA’s outlookWSA, a hearing aid manufacturer, faces an outlook headwind after losing a major US customer contract ending Jan. 1, though it expects to grow in line with or faster than the market in 2026/27 excluding that contract.+Save
MedWatch·Industry news·Business & finance·5d agoAnalysts test Sonova’s growth story as product wins face stocking effects and a lost customerAnalyst scrutiny of Sonova's post-H1 results call focused on inventory stocking effects, the loss of a major customer to a competitor, and increased investment spending.+Save
MedWatch·Financial report·Business & finance·5d agoSonova impairs Consumer Hearing unit by another CHF 68m ahead of saleSonova has written down its Consumer Hearing business by approximately CHF 107m over six months, with CEO Eric Bernard stating the planned divestment remains on track.+Save
MedWatch·Industry news·Business & finance·9d agoNew AI platform and Asia push to keep Sonova ahead of Demant: “We will continue to take share”Sonova CEO Eric Bernard outlines a strategy to outpace Demant through a new AI platform and Asia expansion, while noting cochlear implant growth hinges on FDA approval.+Save
MedWatch·Financial report·Business & finance·9d agoCochlear implants weigh on Sonova’s results despite new launchSonova's cochlear implant segment reported a 10% sales decline and compressed core margin (~6%), attributed to customers awaiting a new AI-powered processor and pricing pressure in the China market.+Save
MedWatch·Financial report·Business & finance·9d agoSonova beats profit forecasts and raises full-year outlookSonova reported first-half earnings that beat profit forecasts and raised its full-year outlook, driven by higher average selling prices for its hearing aids.+Save
MedWatch·Industry news·Business & finance·12d agoDemant goes on offensive with US veterans: “We aim to steadily expand our position”Demant CEO Søren Nielsen identifies the U.S. VA hearing-aid market as a key growth opportunity after six months of market share gains, while acknowledging that rival Sonova currently holds a leading position.+Save
MedWatch·Industry news·Business & finance·12d agoTrustee to seek disqualification of former Audientes managementA bankruptcy trustee is seeking to disqualify former Audientes management amid allegations of possible criminal offenses and a significant gap between the collapsed hearing-tech company's stated claims and actual assets.+Save
MedWatch·Industry news·Business & finance·2w agoDemant CEO in continued focus on cybersecurity after new WSA attack: “I wish them all the best”Demant CEO Søren Nielsen discusses the company's cybersecurity improvements following its 2019 cyberattack, in the context of rival WS Audiology experiencing a third cyber incident.+Save
MedWatch·Financial report·Business & finance·2w agoGN plans DKK 4bn in share buybacks after hearing aid saleGN Group plans DKK 4 billion in share buybacks funded by proceeds from the sale of its hearing aid division to Italian audiology retail group Amplifon.+Save
MedWatch·Industry news·Business & finance·2w agoDemant CEO stays cautious as hearing aid makers race to launch new devicesDemant CEO Søren Nielsen says the hearing aid market has returned to normal growth but remains cautious about Q4 outlook amid competitive new device launches from rivals.+Save
MedWatch·Industry news·Business & finance·2w agoThird cyberattack in seven years shifts scrutiny at WS Audiology from IT to leadershipWS Audiology faces scrutiny over leadership and governance following a third cyberattack in seven years, amid concerns the repeated incidents could undermine trust ahead of a planned stock market listing.+Save
MedWatch·Industry news·Business & finance·3w agoWS Audiology hit by new cyberattackWS Audiology, the Danish hearing aid manufacturer, suffered a cyberattack that granted unauthorized parties access to its internal IT systems, prompting a temporary shutdown of those systems.+Save
MedWatch·Industry news·Business & finance·3w agoAmplifon presses ahead with GN plans while treading carefully around competition authoritiesAmplifon reported strong Q3 results and reaffirmed its 2026 targets while advancing integration planning for GN Hearing, keeping commercial dealings with GN unchanged pending regulatory clearance of the acquisition.+Save
MedWatch·Financial report·Business & finance·3w agoCiti raises Demant price target, still expects it to outperform the marketCiti raised its price target on Demant while maintaining a buy rating, and reiterated a sell rating on rival Sonova, citing updated revenue and earnings estimates for both hearing aid makers.+Save
MedWatch·Industry news·Business & finance·4w agoDemant extends market share gains in US veterans hearing aid channelDemant's US veterans hearing aid channel market share rose for the sixth consecutive month, reaching 24% in September, up from 23.5% in August.+Save
MedWatch·Industry news·Business & finance·4w agoDemant CEO: Bigger management team comes at the right time and adds capacityDemant expands its top management team to five with Bassel Rifai appointed to lead the hearing aid wholesale unit, freeing CEO Søren Nielsen from a role he held directly for years.+Save
MedWatch·Industry news·Business & finance·4w agoDemant faces higher borrowing costs after record German acquisitionDemant faces elevated refinancing costs for short-term debt taken on after a large German acquisition, amid rising long-term bond yields in Europe and the US.+Save
MedWatch·Industry news·Business & finance·4w agoDemant’s new wholesale chief targets global leadership in hearing aidsDemant's newly appointed wholesale chief Bassel Rifai outlines ambitions to become the world's leading hearing aid company, speaking at a German trade fair for the hearing aid industry.+Save
MedWatch·Industry news·Hearing aids·4w agoGN Hearing keeps launch message measured as rivals roll out new platformsGN Hearing CEO Peter Justesen comments on the competitive dynamics of launching a new hearing aid platform simultaneously with rival manufacturers at major industry events.+Save
MedWatch·Industry news·AI & technology·5w agoWSA changes how it promotes key study data as AI takes over searchWSA's marketing head describes how the company is adapting its promotion of key study data as consumers increasingly use AI chatbots rather than Google for search, requiring new visibility and marketing strategies.+Save
MedWatch·Industry news·AI & technology·5w agoDemant CEO says AI hearing aids must strike the right balance on noiseDemant's CEO states that AI-powered hearing aids must balance noise reduction with preserving auditory cues that the brain relies on to interpret its environment.+Save
MedWatch·Industry news·Hearing aids·5w agoWS Audiology CEO says company set out to stand out in crowded launch seasonWS Audiology CEO discusses the company's marketing strategy for the Signia Max hearing aid amid simultaneous new product launches from all four major European hearing aid manufacturers.+Save
MedWatch·Industry news·AI & technology·5w agoSonova CEO says AI raises the stakes for hearing aid evidenceSonova CEO Eric Bernard argues that AI-driven consumer research is increasing the importance of published clinical evidence for hearing aids.+Save